Tic Reduction in Adult Onset Gilles De La Tourette Syndrome Using as Required Nabiximols Spray

BACKGROUND: Tourette syndrome (TS) manifests with motor and vocal tics that can reach disabling intensity. Established therapies may show insufficient relief or side effects. Cannabinoids have demonstrated therapeutic potential in small studies. This report presents buccal Nabiximols “as required” i...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwittay, Maximilian A., Steinbrecher, Andreas, Lobsien, Elmar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ubiquity Press 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344952/
https://www.ncbi.nlm.nih.gov/pubmed/34430070
http://dx.doi.org/10.5334/tohm.613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344952/
https://www.ncbi.nlm.nih.gov/pubmed/34430070
http://dx.doi.org/10.5334/tohm.613

Ejemplares similares